Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Prospectus
Announcements
2022.07.13
POSITIVE PROFIT ALERT ANNOUNCEMENT ON THE ESTIMATED INCREASE IN PROFIT FOR THE I...
2022.06.14
POLL RESULTS OF THE 2021 ANNUAL GENERAL MEETING
2022.05.11
2021 Annual Report
2022.05.11
2021 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
2022.05.05
DELAY IN DESPATCH OF 2021 ANNUAL REPORT
2022.05.05
2022 FIRST QUARTERLY REPORT
2022.05.05
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
2022.05.05
RESIGNATION OF EXECUTIVE DIRECTOR AND CHANGE OF FINANCIAL CONTROLLER
2022.03.31
UNAUDITED ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2021
2022.03.30
Date of Board Meeting
第一页
上一页
6
7
8
9
10
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
